▶ 調査レポート

世界の抹消血管装置市場

• 英文タイトル:Peripheral Vascular Devices Market - Growth, Trends, and Forecast (2019 - 2024)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の抹消血管装置市場 / Peripheral Vascular Devices Market - Growth, Trends, and Forecast (2019 - 2024) / C-MOR-100109資料のイメージです。• レポートコード:C-MOR-100109
• 出版社/出版日:Mordor Intelligence / 2019年9月
• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥442,000 (USD4,250)▷ お問い合わせ
  Multi User¥494,000 (USD4,750)▷ お問い合わせ
  Site License¥624,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、抹消血管装置の世界市場について調査・分析し、抹消血管装置の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。

Market Overview
Peripheral arterial disease (PAD) is caused by a narrowing or blocking of the blood vessels due to a plaque build-up. This condition can lead to tissue death, heart stroke, aneurysms, or kidney diseases, if left untreated. According to the National Institute of Health, one in every 20 American, who is over the age of 50, has PAD. It has been affecting eight to 12 million people in the United States, especially those over 50 years. As the population is growing, the prevalence of the disease is increasing, which could grow from 9.6 million to reach 19 million overall, globally by 2050. With the aging of the global population, it seems likely that PAD will be increasingly common in the future. Hence, the statistics show that the number of PAD is increasing at a faster pace, which is ultimately driving the market of peripheral arterial disease. Other factors, such as the rising demand for minimally-invasive procedures, especially for peripheral arterial disease, lifestyle changes, increase in aging population, and technological advancements have broadened the range of the peripheral vascular devices.

Scope of the Report

Vascular devices can be referred to as a medical device utilized in the case of catheterization post a cardiovascular surgery for the closure and achieving hemostasis in the artery.

Key Market Trends

Atherectomy Devices are expected to dominate the overall market

The market on the basis of device type is segmented into peripheral vascular stents, peripheral transluminal angioplasty (PTA) balloon catheters, peripheral transluminal angioplasty (PTA) guidewires, atherectomy devices, chronic total occlusion (CTO) devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters. The atherectomy devices segment is expected to dominate the overall market, owing to the increasing prevalence of atherosclerosis, rising obesity, lifestyle-related disorders, and hence, the growing adoption.

North America dominates the peripheral vascular devices market

North America dominated the peripheral vascular devices market in 2018 and is expected to grow in the future due to factors, such as the rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in the region. Europe holds the second largest position in the market, which is followed by the APAC region.

Competitive Landscape

The presence of the major market players, such as Abbott, Boston Scientific Corporation, Becton Dickinson and Company, Cook Group, Medtronic, and others is intensifying the market competition. The increasing innovation and rise in investment for various public and private organizations are expected to intensify the industry rivalry across the globe.

Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally-Invasive Procedures, Especially for Peripheral Arterial Disease
4.2.2 Increase in incidence of Peripheral Arterial Disease (PAD)
4.2.3 Lifestyle Changes and Increase in Ageing Population
4.2.4 Technological Advancements have broadened the Range of Peripheral Vascular Devices
4.3 Market Restraints
4.3.1 Delay in Marketing Approval for Peripheral Vascular Devices due to Stringent Regulations
4.3.2 Lack of Proper Reimbursement Policies for Peripheral Vascular Devices
4.3.3 Highly-Fragmented Market Leading To Peripheral Vascular Devices Price Erosion
4.4 Porters Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Peripheral Vascular Stents
5.1.2 Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
5.1.3 Peripheral Transluminal Angioplasty (PTA) Guidewires
5.1.4 Atherectomy Devices
5.1.5 Embolic Protection Devices
5.1.6 Inferior Vena Cava Filters
5.1.7 Other Device Types
5.2 Geography
5.2.1 North America
5.2.1.1 US
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 UK
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Boston Scientific Corporation
6.1.3 Becton, Dickinson and Company
6.1.4 Cook Group
6.1.5 Cordis Corporation
6.1.6 Edward Lifesciences
6.1.7 Medtronic PLC
6.1.8 Volcano Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS